MIRA INFORM REPORT

 

 

Report No. :

338214

Report Date :

25.08.2015

 

IDENTIFICATION DETAILS

 

Name :

GRANULES OMNICHEM PRIVATE LIMITED

 

 

Registered Office :

H. No. 1-123/MH/201, 2nd Floor and 3rd Floor, My Home Hub, Madhapur, Hyderabad-500081, Telangana

Tel. No.:

91- 40-66760000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

02.09.2011

 

 

Com. Reg. No.:

076274

 

 

Capital Investment / Paid-up Capital :

Rs. 414.000 Million

 

 

CIN No.:

[Company Identification No.]

U24233TG2011PTC076274

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAECG3850B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Active Pharmaceutical Ingredients.

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (12)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Even though the company was incorporated on 2nd September 2011 but it has recently commenced its business operations.

 

Mr. Hari Krishna, Assistant General Manager in Finance, provided information of the subject to us and claimed that the company started its activities from October 2014.

 

As per the financial of the year 2014, the company has incurred huge pre-operating expenses which resulted into losses recorded by the company.

 

Further, rating is constrained on account of company’s weak financial position marked by low net worth base and leverage balance sheet profile of the company.

 

However, business is active. Payment terms are reported to be slow.

 

In view of the aforesaid, company can be considered for business dealings on safe and secure trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Hari Krishna

Designation :

Assistant General Finance Manager

Contact No.:

91-7702700898

Date :

24.08.2015

 


 

LOCATIONS

 

Registered/ Corporate Office :

H. No. 1-123/MH/201, 2nd Floor and 3rd Floor, My Home Hub, Madhapur, Hyderabad-500081, Telangana, India

Tel. No.:

91-40-66760000/ 891-2570444

Mobile No.:

91-7702700898 (Mr. Hari Krishna)

Fax No.:

91-40-23115145

E-Mail :

satyabrahmajee.k@granulesomnichem.com

mail@gransulesindia.com

harikrishna.g@gransulesomnichem.com

Website :

http://www.granulesindia.com

 

 

Factory :

Plot No.121 and 122, Jawaharlal Nehru Pharmacy, Vishakhapatnam-531019, Andhra Pradesh, India

 

 

DIRECTORS

 

AS ON 17.07.2014

 

Name :

Mr. Chigurupati Krishna Prasad

Designation :

Nominee Director

Address :

Plot No.512/M, Road No.31,, Jubilee Hills,, Hyderabad-500033, Andhra Pradesh, India

Date of Birth/Age :

02.10.1954

Date of Appointment :

02.09.2011

DIN No.:

00020180

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L24110TG1991PLC012471

GRANULES INDIA LIMITED

Managing director

01-09-2014

31-08-1994

-

Active

NO

2

U67120TG1997PTC027578

TRITON SECURITIES PRIVATE LIMITED

Director

04-06-2007

04-06-2007

-

Active

NO

3

U24230TG2007PTC054839

GIL LIFESCIENCES PRIVATE LIMITED

Director

19-07-2007

19-07-2007

-

Active

NO

4

U15520KA2007PTC044113

KRSMA ESTATES PRIVATE LIMITED

Director

30-07-2008

18-02-2008

-

Active

NO

5

U15520KA2008PTC045582

HARIKRISHNA VINEYARDS PRIVATE LIMITED

Director

30-07-2008

12-03-2008

29-10-2009

Strike off

NO

6

U01130KA2008PTC045488

KRSMA VINEYARDS PRIVATE LIMITED

Director

30-05-2009

06-04-2009

-

Active

NO

7

U24233TG2011PTC076274

GRANULES OMNICHEM PRIVATE LIMITED

Nominee director

02-09-2011

02-09-2011

-

Active

NO

8

U24230TG2000PLC034319

AUCTUS PHARMA LIMITED

Director

22-09-2014

06-11-2013

-

Amalgamated

NO

9

U33112AP1974PTC001808

SANTHI SURGERY PRIVATE LIMITED

Director

30-09-2014

06-09-2014

-

Active

NO

10

U74900KA2014PTC077204

CHIGURUPATI VINEYARDS PRIVATE LIMITED

Director

12-11-2014

12-11-2014

-

Active

NO

 

 

Name :

Mr. George Gwinnett Bompas

Designation :

Nominee Director

Address :

Rue Du Cortil Bailly 47, Lasne, Belgium, 1380, United Kingdom

Date of Birth/Age :

03.11.1960

Date of Appointment :

02.09.2011

DIN No.:

03587826

 

 

Name :

Mr. Peter Marcel Eliane Marie Stuyck

Designation :

Nominee Director

Address :

Heist-Op-Den-Berg Sedert, Hazenstraat 7, Belgium, 2220, Belgium

Date of Birth/Age :

17.06.1956

Date of Appointment :

02.09.2011

DIN No.:

03583387

 

 

Name :

Mr. Venkata Satyanarayana Murthy Vadali

Designation :

Director

Address :

Plot No 28 Sriramnagar Colony, Near Bk Guda Park Balkampet, Hyderabad-500038, Andhra Pradesh, India

Date of Birth/Age :

15.07.1955

Date of Appointment :

17.07.2014

DIN No.:

01568277

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74900GJ2007PLC051338

CARBOGEN AMCIS (INDIA) LIMITED

Director

17-07-2007

17-07-2007

07-04-2012

Active

NO

2

U24233TG2011PTC076274

GRANULES OMNICHEM PRIVATE LIMITED

Director

17-07-2014

02-12-2013

-

Active

NO

3

U24230TG2000PLC034319

AUCTUS PHARMA LIMITED

Nominee director

14-02-2014

14-02-2014

-

Amalgamated

NO

 

 

KEY EXECUTIVES

 

Name :

Satya Brahmajee Kola

Designation :

Secretary

Address :

Flat No. 502 A, Landmark Towers, Miyapur, Hyderabad-500049, Andhra Pradesh, India

Date of Birth/Age :

04.07.1977

Date of Appointment :

26.09.2013

PAN No.:

AHTPK6889P

 

 

Name :

Mr. Hari Krishna

Designation :

Assistant General Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 17.07.2014

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

SA Ajinomoto Omnichem NV, Belgium

32580967

50.00

Granules India Limited, India

32580967

50.00

Total

65161934

100.00

 

 

 

AS ON 15.12.2014

 

Names of Allottees

No. of Shares

 

SA Ajinomoto Omnichem NV, Belgium

10300000

Granules India Limited, India

10300000

Total

20600000

 

 

AS ON 17.07.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

50.00

Bodies corporate

50.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Active Pharmaceutical Ingredients.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Finished Goods

Countries :

Belgium

 

 

Imports :

 

Products :

Raw Material

Countries :

·         South Korea

·         China

·         Switzerland

 

 

Terms :

 

Selling :

Cash, L/C and Credit

 

 

Purchasing :

Cash, L/C and Credit

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Granules India Limited

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Wholesalers, Retailers and Manufacturer

 

Company Name :

Ajinomoto Omnichem, Belgium

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

Bank Name:

Kotak Mahindra Bank Limited

Branch:

S. P. Road, Secunderabad, Hyderabad, Andhra Pradesh, India

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         ING Bank NV Singapore Branch

19-02 Republic Plaza, 9 Raffles Place,, Singapore - 048619, Singapore

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term loans from banks

1486.377

695.438

 

 

 

Total

1486.377

695.438

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S. R. Batliboi and Associates LLP

Chartered Accountants

Address :

Oval office, 18, Llabs Centre, Hitech City, Madhapur, Hyderabad-500081, Andhra Pradesh, India

Income-tax PAN of auditor or auditor's firm :

AGDPM5469N

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Joint venture :

·         SA Ajinomoto Omnichem NV, Belgium

·         Granules India Limited, India (L24110TG1991PLC012471)

 


 

CAPITAL STRUCTURE

 

AFTER 17.07.2014

 

Authorised Capital : Rs. 950.000 Million

 

Issued, Subscribed & Paid-up Capital : Rs. 754.619 Million

 

 

AS ON 17.07.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

70000000

Equity Shares

Rs. 10/- each

Rs. 700.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

65161934

Equity Shares

Rs. 10/- each

Rs. 651.619 Million

 

 

 

 

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

45000000

Equity Shares

Rs. 10/- each

Rs. 450.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

41400000

Equity Shares

Rs. 10/- each

Rs. 414.000 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

414.000

375.100

175.100

(b) Reserves & Surplus

(19.769)

(5.952)

(2.257)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

38.900

30.000

Total Shareholders’ Funds (1) + (2)

394.231

408.048

202.843

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

1486.377

695.438

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

8.578

2.705

0.000

(d) long-term provisions

1.179

0.172

0.000

Total Non-current Liabilities (3)

1496.134

698.315

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

4.178

2.042

1.369

(c) Other current liabilities

130.591

16.633

0.705

(d) Short-term provisions

7.486

0.059

0.371

Total Current Liabilities (4)

142.255

18.734

2.445

 

 

 

 

TOTAL

2032.620

1125.097

205.288

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

155.135

153.577

2.496

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

1704.579

343.248

9.632

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

10.380

84.480

151.688

(e) Other Non-current assets

22.181

22.982

0.000

Total Non-Current Assets

1892.275

604.287

163.816

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

0.000

0.000

0.000

(d) Cash and cash equivalents

129.562

515.663

33.617

(e) Short-term loans and advances

0.643

1.564

7.855

(f) Other current assets

10.140

3.583

0.000

Total Current Assets

140.345

520.810

41.472

 

 

 

 

TOTAL

2032.620

1125.097

205.288

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

0.000

0.000

0.000

 

 

Other Income

0.000

0.000

0.000

 

 

TOTAL                                    

0.000

0.000

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Employees benefits expense

0.701

0.327

0.000

 

 

Other expenses

2.917

3.367

2.257

 

 

TOTAL                                    

3.618

3.694

2.257

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

(3.618)

(3.694)

(Including Financial Expenses)

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

0.501

0.000

 

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(4.119)

(3.694)

(2.257)

 

 

 

 

 

Less

TAX                                                                 

9.699

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(13.818)

(3.694)

(2.257)

 

 

 

 

 

 

Earnings/ (Loss)  Per Share (Rs.)

(0.33)

(0.10)

(0.13)

 

 

PARTICULARS

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

39.000

 

 

 

 

 

Expected Sales (2015-2016): Rs. 1100.000 Million

 

The above information has been parted by Mr. Hari Krishna (Assistant General Finance Manager)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash Generated from Operations

NA

NA

NA

 

 

 

 

Net Cash Flow from used in Operations

NA

NA

NA

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

0.00

0.00

0.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(1.26)

(0.47)

(1.15)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.01)

(0.01)

(0.01)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.77

1.70

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.99

27.80

16.96

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

175.100

375.100

414.000

Reserves & Surplus

(2.257)

(5.952)

(19.769)

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

30.000

38.900

0.000

Net worth

202.843

408.048

394.231

 

 

 

 

Long-term borrowings

0.000

695.438

1486.377

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

695.438

1486.377

Debt/Equity ratio

0.000

1.704

3.770

 

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10423111

28/05/2013 *

621,000,000.00

ING BANK NV SINGAPORE BRANCH

19-02 REPUBLIC PLAZA, 9 RAFFLES PLACE, SINGAPORE, - 048619, SINGAPORE

B77531762

2

10421575

28/05/2013 *

621,000,000.00

DEG - DEUTSCHE INVESTITIONS - UND ENTWICKLUNGSGESE
LLSCHAFT MBH

KAMMERGASSE 22, COLOGNE, - 50676, GERMANY

B77888170

 

* Date of charge modification

 

 

REVIEW OF OPERATIONS:

 

The company is setting up 100% export oriented unit at Ramky Pharma City, SEZ, Parwada Mandal, Vishakapatnam (AP) under the APIIC special economic zone to manufacture active pharmaceutical ingredients. The joint venture Company is setting up 100% export oriented unit at Ramky Pharma city, Parwada Mandal, Visakhapatnam (AP) under the APIIC special economic zone to manufacture active pharmaceutical ingredients. The construction of the unit and various installations are expected to be completed in April 2014 and the trial production is expected to commence by end of June 2014. The Company plans to obtain all necessary regulatory approvals from the U.S. Food and Drug Administration (FDA) and other regulatory authorities by March 31, 2016.

 

 

CORPORATE INFORMATION:

 

Granules Omnichem Private Limited (?the Company) was incorporated on September 2, 2011 as a 50:50 joint venture between Granules India Limited, India and SA Ajinomoto Omnichem N.V, Belgium. The Company is engaged in the business of manufacture and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) and is setting up of a plant at Ramky Pharama City- SEZ situated in Vishakhapatnam, Andhra Pradesh.

 

 


FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Furniture and Fixtures

·         Vehicles

·         Other Equipment

·         Computer Equipments

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 66.51

UK Pound

1

  Rs. 104.01

Euro

1

Rs. 76.27

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

HNA

 

 

Report Prepared by :

IND

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

--

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

--

--PROFITABILIRY

1~10

--

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

2

--RESERVES

1~10

--

--CREDIT LINES

1~10

1

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

12

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.